S201: CAMIDANLUMAB TESIRINE: UPDATED EFFICACY AND SAFETY IN AN OPEN-LABEL, MULTICENTER, PHASE 2 STUDY OF PATIENTS WITH RELAPSED OR REFRACTORY CLASSICAL HODGKIN LYMPHOMA (R/R CHL)

Authors :: C. Carlo-Stella
S. Ansell
P. L Zinzani
J. Radford
K. Maddocks
A. Pinto
G. P. Collins
V. Bachanova
N. Bartlett
I. Bence-Bruckler
M. Hamadani
J. Kline
J. Mayer
K. J. Savage
R. Advani
P. Caimi
R.-O. Casasnovas
T. Feldman
B. Hess
M. Bastos-Oreiro
S. Iyengar
S. Eisen
Y. Negievich
L. Wang
J. Wuerthner
A. F. Herrera
Source :: HemaSphere. 6:102-103
Publication Year :: 2022
Publisher :: Ovid Technologies (Wolters Kluwer Health), 2022.

Tools